DaVita EBIT 2010-2024 | DVA

DaVita EBIT for the quarter ending September 30, 2024 was $0.535B, a 7.85% increase year-over-year.

  • DaVita 2023 EBIT was 1.603B, a 19.69% increase from 2022.
  • DaVita 2022 EBIT was 1.339B, a 25.5% decline from 2021.
  • DaVita 2021 EBIT was 1.797B, a 6.06% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

DaVita EBIT 2010-2024 | DVA

  • DaVita 2023 EBIT was 1.603B, a 19.69% increase from 2022.
  • DaVita 2022 EBIT was 1.339B, a 25.5% decline from 2021.
  • DaVita 2021 EBIT was 1.797B, a 6.06% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.6B
Quest Diagnostics (DGX)$17.4B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.3B
Elanco Animal Health (ELAN)$7.2B
RadNet (RDNT)$5.3B
Option Care Health (OPCH)$3.9B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.9B
Astrana Health (ASTH)$2.9B
Addus HomeCare (ADUS)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$227M
Daxor (DXR)$45M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$13M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M